Team & Board of Directors

Michael Hwang
Michael Hwang

Chairman

Yu-Shen Hsu
Yu-Shen Hsu

Acting President

Bryon Chen
Bryon Chen

Founder

Ming-I Chang
Ming-I Chang

R&D Vice President

Pongo Peng
Pongo Peng

Executive Vice President

Jun-Chin Chen
Jun-Chin Chen

Operation Associate Vice President

Eric Chen
Eric Chen

Chief Financial Officer

Board of Directors

Chairman

Michael Hwang

  • COO, CSO, Medigen Vac. & Biologic.
  • CEO, Bioproduction Plant, National Health Research Institute, Taiwan.
  • CEO, Mycenax Biotech Inc., Taiwan.
  • Sr. Director, Manufacturing; Scientific Director, Primedica Corporation, USA.
  • FDA, Blood and Blood product Div. & Industry, USA.
  • Ph.D., Microbiology / Immunology, Auburn University, USA.
  • MS, Microbiology, Northwestern State University, LA, USA.
  • D.V.M., National Taiwan University, Taiwan.

Director

Yu-Shen Hsu

  • Assistant Director, Department of Biologics, Development Center for Biotechnology.
  • Senior Research Fellow, Development Center for Biotechnology.
  • Assistant professor, the graduate institute of molecular & biotechnology, Da-Yen University.
  • Manager in Technology & Quality Control Division, Formosa Biomedical Inc. (GMP)
  • Ph.D in Biochemistry, University of Oxford, UK.

Director

Bryon Chen

  • Founder of Advagene Biopharma Inc.
  • Strategic Director of contact lens Co. in Taiwan.
  • General Manager of Roche Diagnostics of Taiwan and Great China.
  • AstraZeneca Asia Regional Sales and Marketing Director.
  • Regulatory and Medical affair committee Chairman of IRPMA in Taiwan.
  • Start Astra Taiwan from scratch in1981, General Manager of Astra Taiwan.
  • Pharmacist with MBA.

Director

Gary Hsiao

  • Manager, Bangkok Bank of Thailand, Taipei Branch.
  • Manager, Taishin Bank, Tienmou Branch.
  • Bachelor of business administration, National Taiwan University.

Director

Kimson Wu

  • CEO, 浩群國際生技股份有限公司
  • Regional Manager, AstraZeneca
  • Senior Manager, MSD Taiwan
  • Director of Sales, Chien Chi Pharmaceutical Co., Ltd.
  • M.S., Dominican University, USA

Independent Director

Kwei Hang Chan

  • Director, Generic Drug Review Division, U.S. FDA
  • Partner and Senior Vice President, GloboMax, USA
  • Professor, School of Pharmacy, University of Maryland, USA
  • Adjunct Professor, College of Pharmacy, University of Minnesota, USA
  • Adjunct Professor, Institute of Biopharmaceutical Sciences and Drug Development Center, NYCU
  • Adjunct Professor, Graduate Institute of Technology and Innovation Management, NCCU
  • Head of Clinical Pharmacokinetics, Ciba-Geigy Pharmaceuticals
  • Consultant, Bureau of Pharmaceutical Affairs and Center for Drug Evaluation, Department of Health
  • Fellow, American Association of Pharmaceutical Scientists (AAPS)
  • Senior Consultant, Pan An Intellectual Property Education Foundation, Taiwan
  • Ph.D. in Pharmaceutical Sciences, University of Minnesota, USA

Independent Director

Ariel Hwang

  • Independent Director, The Ambassador Hotel Co., Ltd.
  • Independent Director, Foxsemicon Integrated Technology Inc.
  • Managing Partner, Hwang, Lin & Partners
  • Chief Legal Officer, Taiwan Mobile Co.
  • Judge, Taiwan High Court
  • Judge, Taipei District Court
  • Bachelor of Law, NTU, Taiwan
  • Master, Department of Finance and Economics Law, NTPU, Taiwan
  • EMBA, Department of Finance, NTU, Taiwan

Independent Director

Wendy Chu

  • Corporate Finance Department, Capital Securities Corp.
  • Underwriting Department, Grand Cathay Securities Co.,Ltd
  • Deputy General Manager, Underwriting Department, Grand Fortune Securities Co.,Ltd
  • Independent Director, ZillTek Technology.
  • M.S., Institute of Business and Management, NYCU